How Analysts Feel About Xenon Pharmaceuticals Inchares (NASDAQ:XENE) After Increase in Sellers?

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Logo

The stock of Xenon Pharmaceuticals Inchares (NASDAQ:XENE) registered an increase of 22.97% in short interest. XENE’s total short interest was 195,400 shares in July as published by FINRA. Its up 22.97% from 158,900 shares, reported previously. With 56,300 shares average volume, it will take short sellers 4 days to cover their XENE’s short positions.

The stock decreased 0.10% or $0.01 during the last trading session, reaching $10.16. About 14,500 shares traded. Xenon Pharmaceuticals Inc. (NASDAQ:XENE) has risen 51.67% since July 14, 2018 and is uptrending. It has outperformed by 47.24% the S&P500.

Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing differentiated therapeutics for orphan indications in Canada. The company has market cap of $261.85 million. The firm uses Extreme Genetics, a core enabling discovery platform for the discovery of validated drug targets by studying rare human diseases with extreme traits, including diseases caused by mutations in ion channels, known as channelopathies. It currently has negative earnings. It offers Glybera, a gene therapy product for the treatment of patients with orphan lipid disorder lipoprotein lipase deficiency.

More notable recent Xenon Pharmaceuticals Inc. (NASDAQ:XENE) news were published by: which released: “Is Spok Holdings Inc (SPOK) A Good Stock To Buy? – Yahoo Finance” on June 28, 2019, also with their article: “Xenon Provides Key Regulatory Updates on XEN007 and XEN1101 – GlobeNewswire” published on January 28, 2019, published: “3 Pharma Stocks Expected to Double – Schaeffers Research” on March 29, 2019. More interesting news about Xenon Pharmaceuticals Inc. (NASDAQ:XENE) were released by: and their article: “Reader Inquiry: Can The Run Up Continue For Xenon Pharmaceuticals? – Seeking Alpha” published on May 30, 2018 as well as‘s news article titled: “Xenon: An Updated Investment Analysis – Seeking Alpha” with publication date: September 10, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.